Global Animal Antibiotics and Antimicrobials Market: Increasing incidence of zoonotic diseases is driving the market.

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 3.6 % from USD 4.52 billion in 2020 to reach USD 5.78 Billion by 2027. Factors such as increasing animal population, rising demand for animal-derived food products, increasing incidences of zoonotic diseases, implementation of regulations for preventing the spread of animal diseases, and rising demand for pet insurance and growing animal health expenditure are the major factors driving the growth of the global animal antibiotics and antimicrobials market. However, dearth of new antibiotics, growing resistance to antimicrobials and antibiotics, and replacement of routine prophylactic use of antibiotics by good husbandry and hygiene practices may hinder the growth of this market to certain extent.

Growing demand for livestock products is anticipated to positively influence the global animal antimicrobials and antibiotics market over the next seven years. Macrolides, tetracycline, quinolones, penicillin, cephalosporin, sulphonamides and amino glycosides are different animal antimicrobials and antibiotics products. Tetracycline which is an important raw material for antibiotics has witnessed rapid growth in the recent past. Strong demand for penicillin based antibiotics is expected to bolster the animal antimicrobials and antibiotics market. Rise in demand for animal protein products is touted to aid the global market. Increasing initiatives concerning animal health and welfare are expected to aid the overall global market for animal antimicrobials and antibiotics market. Increasing animal disease outbreaks are touted to play a key role in complimenting the global animal antimicrobials and antibiotics market.

Growing livestock population is anticipated to further assist the animal antimicrobials and antibiotics market. End-use industries such animal meat industry has witnessed rapid growth over the past few years and is expected to witness brisk development over the forecast period. Rise in dairy product demand is presumed to drive the global antimicrobials and antibiotics market. Regulations imposed by agencies such as Food and Drug Administration on excessive antibiotics usage is touted to result in sluggish market growth. High in-feed enzymes usage in food products is anticipated to hamper the overall growth for animal antimicrobials and antibiotics market. Rise in industry competition is expected to hamper the global market growth.

Cheaper substitutes available in the market are expected to retard the animal antimicrobials and antibiotics market growth. Increasing resistance to antibiotic is a key reason that is expected to hamper the animal antimicrobials and antibiotics market growth. Good and hygienic husbandry practices leading to lesser antibiotics usage are slated to retard the animal antimicrobials and antibiotics market growth over the next seven years. Large number of industry participants resulting in severe price wars is projected to curtail profits and degrade animal antimicrobials and antibiotics industry performance. Initiatives to develop novel technologies offer ample opportunities for the existing as well as new industry participants.

Some of the prominent players in the animal antibiotics and antimicrobials market include Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bayer AG (Germany), Virbac (France), BoehringerIngelheim GmbH (Germany), Sanofi (France), CevaSanteAnimale (France), Vetoquinol S.A. (France), and Dechra Pharmaceuticals PLC (U.K.).

North America is expected to rise at significant rate and lead the market over the forecast period. Rising number of companion animal healthcare expenditure, increasing demand for animal-derived food products, and presence of various food-producing animals has led the demand for animal antibiotics and antimicrobials. Another factor contributing in the growth in this market is rising awareness about zoonotic diseases.
Asia Pacific is also expected to offer lucrative growth opportunities in the animal antibiotics and antimicrobials market. This growth can be attributed to the changing dietary habits, progressive urbanization, and increasing pet adoption. China, India, Vietnam, Malaysia, and Japan are major countries due to rising demand for animal products in end-use industries. In addition, there is boom in animal protein demand and growing companion animal ownership that is likely to provide a fillip in this market. Middle East and Africa is also expected to rise at a high growth rate over the forecast period.